Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?
Authors:
Open Access
- 6 May 2020
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 7, 550759
Abstract
After the outbreak of corona virus-19 disease (COVID-19) in Italy, at 3 April 2020 we count about 120'000 infected and 14000 dead (1). Following a decree of the president of the council of ministers (DPCM) of 9 th march 2020 mass exodus occurred to return to their families, of those who had moved to the north mainly for work or study purposes, thus bringing the infection in the southern regions. This made it necessary to think of strategies to be implemented to contain and record the movements of patient sentering hospital settings, such as cancer patients. From scientific literature it is evident that about 19.4% of the deaths with the coranavirus had an oncological pathology as comorbidity. The data reveal a connection between anticancer therapies and susceptibility to the corona virus, in particular if you have lung cancer, in fact about 28% of patients were affected by this pathology (2,3).The measures that we are adopting provide for the correct use of personal protective equipment (PPE) by all healthcare personnel and also by patients.In addition, patients were prevented from entering the ward with carers so as not to crowd corridors or rooms at the time of visits.A very effective measure that is being implemented is the conduct of a pre-triage both by telephone and in presence. Telephone pre-triage is performed the day before therapy by contacting each patient and asking if he has had fever or cough in the last 15 days, if he has had possible contacts at risk and by sending the blood analysis via e-mail.Sending the blood analysis is the fundamental part of telephone pre-triage because it allows us to view the patient's parameters in advance and decide whether or not to have him go to the hospital.In fact, many times it is decided to postpone the therapy for even two weeks to avoid that the patient has too many contacts at risk.On the other hand, pre-triage in presence provides for a second interview and the measurement of the temperature in the reception room on the day of the therapy to further intensify the checks.Moreover according to the Campania Region official press release n° 96 on 30 th march 2020, referring decree n°45 on 6 th march 2020, also sierological tests will be done on patients in the pretriage in presence. Serological tests are quick qualitative tests which research antibody IgM or IgG anti coronavirus' antigen (8).For patients who require ordinary hospitalization, elderly and with higher comorbidity or testicular cancer patients who require several days of treatment, a preliminary evaluation of treatment change (exemple: hormonal therapy for prostate cancer suspending chemotherapy), a wad is being performed before hospitalization takes place in order to avoid that they can infect other patients or healthcare personnel (Table 1). Quick serological tests will be done also on hospitalized patients to implement infection control during hospitalization's days.Undergoing all health professionals and thus identify any asymptomatic positives and then divide the staff into weekly teams. At the end of each week, the staff will be subjected to a swab to highlight anyinfections and another team will change them to ensure continuity in the service.Taking as an example the OU in Pagani, the whole team is composed of 8 doctors, 2 nurses and data managers and it could be divided into two parts for each week (table 2).Plans are being made to create an online platform where all patients belonging to the OU could be registered and where can also access the respective doctor of general medicine (DGM) who can enter the patient's basal data and thuskeep the hospital always updated. In fact, DGM would be a powerful means of keeping the population under control, especially the risk groups such as cancer patients. They could telephone them daily and update their online files thus allowing oncologists to also be able to carry out remote consultations in case of ailments that do not require a visit, so as to delay their access to the hospital and alleviate the suffering that can result from isolation.In these situations of tension and forced quarantine, those with the greatest psychological repercussions are the patients whom most need treatment and attention because of the therapies they carry out.Instead, by creating such a platform, they would never miss their doctor, feeling comforted and followed even in an atmosphere of tension. Moreover all the measures above help us to controll patients movements in the hospital and also to manage their therpay in order to not expose them to risks. Infact telephone pre-triage creates a connection between patients and healthcare personnel and so they could tell us all their anxiety and dubt. However sending blood analysis is the most important tool in the management of the therapy because we can decide if is possible to do or not therapy before patients come and if is not determinant for oncological outcome delay therapy for two weeks in order to avoid other contact for the patients.Our experience using these methods is positive, infact we have reduced the number of patients that access to the OU even only for an advice or for controlling blood analysis and so we can apply better regional and national directives about coronavirus restraint.Currently, the Italian Medicines Agency (AIFA) has approved the protocol drawn up by the team of Prof. Paolo Antonio Ascierto for the use of the monoclonal antibody Tocilizumab which has as its main objective to reduce the death rate from corona virus. In fact, the afore mentioned drug bounds to the IL-6 receptor preventing it from binding and thus blocking the activation of other cytokines that would damage the lung parenchyma (4). There is another drug, still not approved by AIFA, which is administered for compassionate use, namely Remdesivir an antiviral (4).Both are bringing relief to patients with COVID-19 but the main strategy on which to base the fight against the virus is prevention...Keywords
This publication has 8 references indexed in Scilit:
- Telemedicine Online Visits in Urology During the COVID-19 Pandemic—Potential, Risk Factors, and Patients’ PerspectiveEuropean Urology, 2020
- The Shifting Landscape of Genitourinary Oncology During the COVID-19 Pandemic and how Italian Oncologists Reacted: Results from a National SurveyEuropean Urology, 2020
- Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 PandemicEuropean Urology, 2020
- Caring for Patients With Cancer During the COVID-19 Outbreak in ItalyJAMA Oncology, 2020
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortalityInternational Journal of Antimicrobial Agents, 2020
- COVID-19 and Italy: what next?The Lancet, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsCancer, 2006